SCHEMBL19982003

SCHEMBL19982003

CC1CCCN(C(=O)[C@@H](N)C(C)C)C1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 13/20 0.50
DPP7 Q9UHL4 8/20 0.50
DPP8 Q6V1X1 6/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
DPP9 Q86TI2 4/20 0.49
FAP Q12884 3/20 0.49
PREP P48147 2/20 0.49
PITRM1 Q5JRX3 1/20 0.49
LIPE Q05469 2/20 0.47
ACHE P22303 1/20 0.47
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
RECQL P46063 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2735526 1.00 DPP4 (0.50) DPP4DPP7DPP8ALDH1A1LMNA
SCHEMBL17176286 0.90 DPP4 (0.59) DPP4DPP7DPP8ALDH1A1DPP9
SCHEMBL17176288 0.90 DPP4 (0.59) DPP4DPP7DPP8ALDH1A1DPP9
SCHEMBL2735521 0.90 DPP4 (0.59) DPP4DPP7DPP8ALDH1A1DPP9
SCHEMBL2735537 0.87 ALDH1A1 (0.54) DPP4DPP7DPP8ALDH1A1LMNA
SCHEMBL13198912 0.82 ALDH1A1 (0.56) DPP7ALDH1A1LMNALIPEACHE
SCHEMBL13198906 0.82 ALDH1A1 (0.56) DPP7ALDH1A1LMNALIPEACHE
SCHEMBL478903 0.82 ALDH1A1 (0.56) DPP7ALDH1A1LMNALIPEACHE
SCHEMBL2735582 0.82 DPP4 (0.50) DPP4DPP7DPP8ALDH1A1LMNA
SCHEMBL11844731 0.79 ALDH1A1 (0.62) DPP7ALDH1A1LMNALIPEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11292783-B2 Substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists RESEARCH TRIANGLE INSTITUTE (NC) 2022-04-05 US disclosed
EP-3512832-B1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS RES TRIANGLE INST (US) 2021-05-19 EP disclosed
US-20190263781-A1 Tetrahydroisoquinoline Kappa Opioid Antagonists RESEARCH TRIANGLE INSTITUTE (US) 2019-08-29 US disclosed
WO-2018053222-A1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS RESEARCH TRAINGLE INSTITUTE (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11292783-B2 Substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists OPRK1, OPRD1, OPRM1 DPP4 3504/4885DPP7 4157/4885DPP8 4369/4885
US-20190263781-A1 Tetrahydroisoquinoline Kappa Opioid Antagonists OPRK1, OPRD1, OPRM1 DPP4 3757/4885DPP7 4144/4885DPP8 4145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.